abstracts
Oral Session
O1–030 - Phase II Study of Palbociclib (PD-0332991) + Letrozole vs Letrozole Alone in First-Line ER + /HER2- Advanced Breast Cancer

https://doi.org/10.1093/annonc/mdt459.9Get rights and content
Under an Elsevier user license
open archive

Cited by (0)